This course aims to provide students with a clear understanding of the scientific basis underlying the principles and clinical practice of oncology and the development, evaluation and implementation of new treatments. This will be underpinned by a thorough knowledge of cancer biology and pathology, drug development and research methodologies. This knowledge will provide a good grounding in the clinical practice of oncology which will enhance prospects for those pursuing a clinical academic career.
Compulsory modules: cancer biology; cancer pharmacology; pathology of cancer; ablative therapies; cancer prevention and screening; drug development; genomic approaches to human diseases; imaging; paediatric and adolescent oncology; site specific tumour treatment; research methods; dissertation. Option modules: Biological therapies; molecular targeted therapies and immunotherapy for blood cancers.
|Duration & Attendance||Qualification||Tuition fees||Fee type|
- This course is aimed at clinicians, but will be open to any applicant who meets the entry requirements. For admission to the programme applicants will need either a good medical degree or degree equivalent from a recognised academic institution or an appropriate professional qualification or experience acceptable to the course director and Institute Postgraduate Tutor. International applicants: Students from outside of the UK help form a global community here at Queen Mary. For detailed country specific entry requirements please visit the International section of our website. If your 1st language is not English, you must provide evidence of your English language proficiency. If you do not meet language or scholarly requirements it might be possible for you to undertake foundation or pre-sessional programmes that will prepare you for the masters programme.